Direct acting oral anticoagulant: Bench to bedside

Journal Title: Medical Journal Armed Forces - Year 2017, Vol 73, Issue 3

Abstract

Vitamin K antagonists are an effective group of oral anticoagulants. However because of genetic variability in their metabolism and multiple food and drug interactions, these drugs have narrow therapeutic window with unpredictable anticoagulant effects requiring constant monitoring. Several newer direct acting oral anticoagulants have been approved for prevention of stroke in patients with nonvalvular atrial fibrillation and treatment or prevention of venous thromboembolism. The direct acting oral anticoagulants include the direct thrombin inhibitor (dabigatran) and the factor Xa inhibitors (rivaroxaban, apixaban, and edoxaban). These have a better safety and efficacy profile compared to Vitamin K antagonists. Some of the limitations of these drugs include increased risk of gastrointestinal bleeding (except apixaban), increased risk for thrombotic complication upon sudden cessation of therapy and inability to monitor the anticoagulation efficacy. Recent availability of the antidote to these drugs has further strengthened their safety profile. In the current review we will discuss these agents with focus on their potential clinical uses and limitations.

Authors and Affiliations

DS Chadha

Keywords

Related Articles

Wishing away Plagiarism in Scientific Publications! Will it work? A situational analysis of Plagiarism policy of journals in PubMed

Background: Plagiarism remains a scourge for the modern academia. There are inconsistencies in the plagiarism policy scientific journals. The aims of this study was to analyze types of published articles on 'Plagiarism'...

Effectiveness of an intervention package on knowledge, attitude, and practices of food handlers in a tertiary care hospital of north India: A before and after comparison study

Background: Food-borne illnesses have been a recognized hazard for decades. Recent promulgation of Food Safety and Standards Act (FSSA), 2006, indicates the concern of our Govt. for food safety. Research on effectiveness...

Zika: An enormous public health challenge for a miniscule virus

Zika virus (ZIKV) infection has recently affected 4 million people across the globe. The World Health Organization has declared Zika a ‘‘Public Health Emergency of International Concern’’. The disease is caused by an arb...

Publish first, retract later. Is it time for introspection?

Retraction of a scholarly article has long been considered an important self regulatory and corrective measure where there have been serious research flaws, error or publication misconduct. Retraction of a published arti...

Determinants of injuries and Road Traffic Accidents amongst service personnel in a large Defence station

Background: Injuries are assuming epidemic proportions globally; and in India. Also, previous decade witnessed carnage on Indian roads, with nearly 12 lakh people killed and 55 lakhs disabled in road crashes. The trend i...

Download PDF file
  • EP ID EP618830
  • DOI 10.1016/j.mjafi.2016.11.013
  • Views 80
  • Downloads 0

How To Cite

DS Chadha (2017). Direct acting oral anticoagulant: Bench to bedside. Medical Journal Armed Forces, 73(3), 274-281. https://europub.co.uk/articles/-A-618830